エピソード

  • EASL Chronic HBV Infection Guidelines 2025 [Part 2]: Treatment and monitoring
    2025/05/28

    This AI-generated summary is based on the following references:

    1. Cornberg M, Sandmann L, Jaroszewicz J, Kennedy P, Lampertico P, Lemoine M, et al. EASL Clinical Practice Guidelines on the management of hepatitis B virus infection. Journal of Hepatology. 2025 May [DOI: 10.1016/j.jhep.2025.03.018].


    続きを読む 一部表示
    33 分
  • EASL Chronic HBV Infection Guidelines 2025 [Part 1]: Screening and diagnosis
    2025/05/28

    This AI-generated summary is based on the following references:

    1. Cornberg M, Sandmann L, Jaroszewicz J, Kennedy P, Lampertico P, Lemoine M, et al. EASL Clinical Practice Guidelines on the management of hepatitis B virus infection. Journal of Hepatology. 2025 May [DOI: 10.1016/j.jhep.2025.03.018]

    続きを読む 一部表示
    19 分
  • HIV-1 elite controllers: a review
    2025/05/07

    This AI-generated summary is based on the following references:

    1. Gebara NY, El Kamari V, Rizk N. HIV-1 elite controllers: an immunovirological review and clinical perspectives. Journal of Virus Eradication. 2019 Jul;5(3):163–6.

    ‌2. Khan M, Bradshaw D, Brown CS, Haddow J, Patel P, Tosswill JHC, et al. Characterization of Rare Spontaneous Human Immunodeficiency Virus Viral Controllers Attending a National United Kingdom Clinical Service Using a Combination of Serology and Molecular Diagnostic Assays. Open Forum Infectious Diseases. 2023 Mar 1;10(5).

    ‌3. Giliauskas D. Considerations for the clinical management of HIV elite controllers – The Ontario HIV Treatment Network. 2018.

    続きを読む 一部表示
    16 分
  • HIV and Cardiovascular Disease: Risk and Management
    2025/05/03

    This AI-generated summary is based on the following references:

    1. Sorina Șoldea, Iovănescu M, Mihaela Berceanu, Oana Mirea, Raicea V, Beznă MC, et al. Cardiovascular Disease in HIV Patients: A Comprehensive Review of Current Knowledge and Clinical Implications. International Journal of Molecular Sciences. 2025 Feb 21;26(5):1837–7.

    2. Ghandakly E, Rohit Moudgil, Holman K. Cardiovascular disease in people living with HIV: Risk assessment and management. Cleveland Clinic Journal of Medicine. 2025 Mar 1;92(3):159–67.

    3. Henning RJ, Greene JN. The epidemiology, mechanisms, diagnosis and treatment of cardiovascular disease in adult patients with HIV. American Journal of Cardiovascular Disease. 2023 Apr 15;13(2):101.

    続きを読む 一部表示
    23 分
  • HIV and Stroke: risks and implications
    2025/05/03

    An AI-generated discussion based on the following articles:

    1. Ismael S, Khan MM, Kumar P, Sunitha Kodidela, Golnoush Mirzahosseini, Kumar S, et al. HIV Associated Risk Factors for Ischemic Stroke and Future Perspectives. International Journal of Molecular Sciences. 2020 Jul 26;21(15):5306–6.

    2. Benjamin LA, Bryer A, Emsley HC, Khoo S, Solomon T, Connor MD. HIV infection and stroke: current perspectives and future directions. The Lancet Neurology. 2012 Sep 17;11(10):878–90.

    3. Singer EJ, Valdes-Sueiras M, Commins DL, Yong W, Carlson M. HIV stroke risk: evidence and implications. Therapeutic Advances in Chronic Disease. 2013 Jan 7;4(2):61–70.

    続きを読む 一部表示
    14 分